Importer of Controlled Substances; Notice of Registration, 20002 [2010-8794]
Download as PDF
<![CDATA[
20002
Federal Register / Vol. 75, No. 73 / Friday, April 16, 2010 / Notices
Dated: March 29, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated October 16, 2009, and
published in the Federal Register on
October 28, 2009, (74 FR 55587), Varian
Inc., Lake Forest, 25200 Commercentre
Drive, Lake Forest, California 92630,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
II:
Drug
Schedule
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Phencyclidine (7471) ....................
1-Piperidinocyclohexanecarbonitrile (8603).
Benzoylecgonine (9180) ...............
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Varian Inc., to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Varian
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: March 29, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Antitrust Division
Importer of Controlled Substances;
Notice of Registration
[FR Doc. 2010–8797 Filed 4–15–10; 8:45 am]
DEPARTMENT OF JUSTICE
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993 Joint Venture Under Tip
Award Number: 7ONANB1OHOO1
By Notice dated November 23, 2009,
and published in the Federal Register
on December 2, 2009 (74 FR 63156),
Mylan Pharmaceuticals Inc., 781
Chestnut Ridge Road, Morgantown,
West Virginia 26505, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in schedule
II:
Drug
Schedule
Oxycodone (9143) ........................
Hydromorphone (9150) ................
The company plans to import the
listed controlled substances in finished
dosage form (FDF) for analytical testing
and distribution for clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Mylan Pharmaceuticals Inc. to import
the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Mylan Pharmaceuticals Inc.
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: March 29, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–8794 Filed 4–15–10; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2010–8796 Filed 4–15–10; 8:45 am]
BILLING CODE 4410–09–P
VerDate Nov<24>2008
16:37 Apr 15, 2010
Jkt 220001
II
II
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Notice is hereby given that, on
February 3, 2010, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), the
Joint Venture under TIP Award Number:
7ONANB1OHOO1 (‘‘Brewer-Swent’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing (1) the identities
of the parties to the venture and (2) the
nature and objectives of the venture.
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to section 6(b) of the Act, the
identities of the parties to the venture
are: Brewer Science, Inc., Rolla, MO;
and SouthWest Nano Technologies,
Norman, OK. The general area of
Brewer-Swent’s planned activity is to
demonstrate the production of low-cost,
high-quality metallic and
semiconducting single wall carbon
nanotube inks.
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 2010–8573 Filed 4–15–10; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—OpenSAF Foundation
Notice is hereby given that, on March
11, 2010, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), OpenSAF Foundation
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Aricent Technologies
(holding) Ltd., Gurgaon, Haryana,
INDIA; GoAhead Software, Belleirue,
WA; and Oracle Corporation, Santa
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 75, Number 73 (Friday, April 16, 2010)]
[Notices]
[Page 20002]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8794]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated November 23, 2009, and published in the Federal
Register on December 2, 2009 (74 FR 63156), Mylan Pharmaceuticals Inc.,
781 Chestnut Ridge Road, Morgantown, West Virginia 26505, made
application by letter to the Drug Enforcement Administration (DEA) to
be registered as an importer of the basic classes of controlled
substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
finished dosage form (FDF) for analytical testing and distribution for
clinical trials.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Mylan Pharmaceuticals Inc. to import the basic classes
of controlled substances is consistent with the public interest, and
with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA
has investigated Mylan Pharmaceuticals Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: March 29, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-8794 Filed 4-15-10; 8:45 am]
BILLING CODE 4410-09-P
